GlassScriptPhysician profile
Bobbie J Thornton
NPI 1770952525
$1,190.58
in general payments reported to CMS, 2019-2025
14 companies · $418 in 2025
The $418 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.00 · 2022: $140 · 2023: $236 · 2024: $381 · 2025: $418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,035.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,034.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $166.53 | 2024-2025 | Arexvy, Shingrix, Bexsero |
| Lilly USA, LLC | $152.09 | 2023-2024 | Mounjaro |
| Exact Sciences Corporation | $145.09 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $122.49 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $119.27 | 2021-2025 | Airsupra |
| Medtronic, INC. | $102.48 | 2023 | Corevalve Evolut R |
| Abbott Laboratories | $75.79 | 2023-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Novo Nordisk INC | $67.63 | 2023-2025 | |
| Averitas Pharma INC. | $67.40 | 2025 | Qutenza |
| Novartis Pharmaceuticals Corporation | $53.74 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $44.28 | 2022-2025 | |
| Dexcom, INC. | $30.62 | 2025 | Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161) |
| Merck Sharp & Dohme LLC | $27.33 | 2025 | Capvaxive, Rotateq, M-M-R II |
| Cranial Technologies, INC | $15.84 | 2024 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bobbie Thornton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.